Lewis Fan, Managing Director and Senior China Analyst, Rodman & Renshaw,
Lewis Fan is a Managing Director and Senior China Analyst at Rodman & Renshaw. Prior to joining Rodman, Mr. Fan was the Chief Financial Officer of China-Biotics, Inc. Before that, he was a senior analyst at Brean Murray, Carret covering small cap Chinese companies. Mr. Fan also served as an equity analyst at UBS covering large cap biotech, and as an emerging markets strategist at Deutsche Bank covering Asian, EEMEA, and Latin American markets. Mr. Fan’s opinions have been cited in a wide variety of media such as Washington Post, Investor’s Business Daily, DWNews, PharmAsia News, and theStreet.com TV.
Mr. Fan holds an MBA in finance from the Stern School of New York University, an MS in medicinal chemistry from the University of Michigan, and a BA with honors in biology and chemistry from Luther College. Prior to his Wall Street career, Mr. Fan spent over 5 years as a scientist at Schering-Plough focusing on natural products drug discovery research. |